Clinical Trial Update: Glycemic Relapse Prevention: Maintenance Dose Assessment [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating maintenance-dose strategies to prevent glycemic relapse in Type 2 Diabetes. The study status is completed and sponsored…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED